Cable Hill Partners, LLC Axsome Therapeutics, Inc. Transaction History

Cable Hill Partners, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2018 Apr 20, 2018	SELL	$2.35 - $5.6 $2,350 - $5,600	-1,000 Closed	0 $0
Q3 2017 Oct 27, 2017	BUY	$4.65 - $6.1 $4,650 - $6,100	1,000	1,000 $6,000

326

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.27B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Cable Hill Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Cable Hill Partners, LLC with notifications on news.